Spain’s largest life sciences VC is moving upstream with InceptionBio, its first fund dedicated to the riskiest stage of biotech: company creation from university and research centre spinouts. CDTI is an anchor LP. The target is at least three new companies in 2026. The hardest part of turning academic science into a biotech company is […]

This story continues at The Next Web